- Function: Regulation of Blood System
- Place of Origin: China
- Brand Name: OEM
- Model Number: Oblong
- Dosage Form: Capsules
- Dosage Form: Softgel Capsule
- Size: 20#Oblong
- Certificate: GMP, ISO22000, HACCP, HALAL
- MOQ: 500,000 Caps or negotiable
Packaging & Delivery
|Packaging Details:||Bulk in carton, blister or bottle with label on client's brand|
|Delivery Detail:||3-5 weeks|
SpecificationsNutrition supplement Salmon oil Softgel Capsule
1 Clear,light yellow liquid
2 Size 20# Oblong (1000mg)
3 GMP certified
Nutrition supplement Salmon oil Softgel Capsule
Product: Salmon oil Softgel Capsule
Description: Clear, light yellow liquid
Size: 20# Oblong (1000mg)
Content: EPA18%/ DHA12%
Manufacturer: Pharmatech Asia Group
Certificates: Pharmaceutical GMP,
Site Licence issued by Health Canada
EPA (Eicosapentaenoic acid):
The molecular formula: C20H30O2
The molecular weight: 302.451
DHA (Docosahexaenoic acid):
The molecular formula: C22H32O2
The molecular weight: 328.488
The salmon oil that is derived from salmon fish, have a relatively shorter life span compared to other fish. These are also smaller in size and are also a high source of omega-3 fatty acids.
There is strong scientific evidence from human trials that omega-3 fatty acids from fish or fish oil supplements (EPA + DHA) significantly reduce blood triglyceride levels. Benefits appear to be dose-dependent. Fish oil supplements also appear to cause small improvements in high-density lipoprotein ("good cholesterol"); however, increases (worsening) in low-density lipoprotein levels (LDL/"bad cholesterol") are also observed.
Omega-3 fatty acids may increase the risk of bleeding, although there is little evidence of significant bleeding risk at lower doses. Very large intakes of fish oil/omega-3 fatty acids ("Eskimo" amounts) may increase the risk of hemorrhagic (bleeding) stroke. High doses have also been associated with nosebleed and blood in the urine. Fish oils appear to decrease platelet aggregation and prolong bleeding time, increase fibrinolysis (breaking down of blood clots), and may reduce von Willebrand factor.
Skin rashes have been reported rarely.
Pregnancy and Breastfeeding:
It is not known if omega-3 fatty acid supplementation of women during pregnancy or breastfeeding is beneficial to infants. It has been suggested that high intake of omega-3 fatty acids during pregnancy, particularly DHA, may increase birth weight and gestational length (254). However, higher doses may not be advisable due to the potential risk of bleeding. Fatty acids are added to some infant formulas.
The World Health Organization and governmental health agencies of several countries recommend consuming 0.3-0.5 grams of daily EPA + DHA and 0.8-1.1 grams of daily α-linolenic acid. A doctor and pharmacist should be consulted for dosing for other conditions.
|Buyer||Product Name||Price||Quantity||Order Time(GMT+8)|